Literature DB >> 18755867

Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome.

A Meglic1, S Grosek, M Benedik-Dolnicar, T Avcin.   

Abstract

A 4-year-old boy with an atypical course of haemolytic uremic syndrome (HUS), who developed microangiopathic antiphospholipid-associated syndrome (MAPS) with signs of multiple organ failure during the course of his disease, is reported. Early and aggressive treatment with intravenous gammaglobulin, pulse methylprednisolone and plasmapheresis resulted in an excellent clinical recovery. Our patient showed a concomitant presence of multiple factors that could precipitate atypical HUS, including positive antiphospholipid antibodies, decreased level of factor H and positive anti-ADAMTS-13 antibodies. We suggest that, along with infections, autoimmune conditions or defined genetic abnormalities of complement regulatory genes, MAPS should be considered among the pathogenic mechanisms in patients with atypical HUS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755867     DOI: 10.1177/0961203308091634

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome.

Authors:  Shunsuke Noda; Masao Ogura; Akiko Tsutsumi; Tomohiro Udagawa; Koichi Kamei; Kentaro Matsuoka; Hiroshi Kitamura; Tatsuya Atsumi; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2011-12-31       Impact factor: 3.714

3.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

Review 4.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 5.  The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.

Authors:  Chris Wincup; Yiannis Ioannou
Journal:  Front Pediatr       Date:  2018-11-27       Impact factor: 3.418

6.  Digital gangrene in a child with atypical hemolytic uremic syndrome associated with anti-factor H antibodies.

Authors:  K P Sathe; A Ohri; A Mishra; U Ali
Journal:  Indian J Nephrol       Date:  2016 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.